|Date:||November 16, 2018 | 8:00 am – 5:00 pm
November 17, 2018 | 8:30 am – 3:30 pm
|Location:||Eilan Hotel & Spa
18603 La Cantera Terrace
San Antonio, TX 78256
November 2, 2018
» Poster size: 36″ x 36″ or 36″ x 48″ or 36″ x 54″
» Must have at least two (2) authors
» Abstract limited to 250 words maximum
» May use either results or methodology
Click here to book a room at the Eilan.
(Note: the $22 Destination Amenity Fee has been waived for attendees; however, it still prints out on the guest confirmation – please disregard.)
Shuttle service will be available from UT Health San Antonio and UTSA.
Click here for shuttle times.
The Infectious Disease Clinical Research Program (IDCRP) is committed to reducing the impact of infectious diseases in the military population through collaborative clinical research. The IDCRP HIV Research Area is focused on ensuring the long term health and function of infected service members and beneficiaries as well as primary HIV and secondary STI prevention efforts.
Dr. Craft directs a research laboratory devoted to understanding the immune response to pathogens and vaccines, and dissecting and treating autoimmune diseases, such as systemic lupus erythematosus. He is Director of the Investigative Medicine Program at Yale, a unique program designed to provide Ph.D. training for physicians. He is co-founder of L2Diagnostics, formed in partnership with Yale University and devoted to discovery of new diagnostics and therapeutic targets for immunological and infectious diseases.
Dr. Mobley’s laboratory is interested in the molecular mechanisms of bacterial pathogenesis. They are studying virulence mechanisms of uropathogenic Escherichia coli and Proteus mirabilis that cause urinary tract infection and are using a large-scale selection process that incorporates bioinformatic, genomic, transcriptomic, and proteomic screens to identify, in an unbiased manner, potential vaccine candidates. They are also identifying immunological correlates of protection.
Research in the Roy laboratory focuses on the host-pathogen interface. Using multi-disciplinary approaches, his laboratory has discovered many novel mechanisms that intracellular pathogens use to modulate host membrane transport pathways, which allow these pathogens to evade cell autonomous defenses and create novel organelles that permit bacterial replication.
Dr. Schultz-Cherry is internationally known for her expertise in host factors in influenza virus pathogenesis and has provided fundamental contributions to microbiology and human and animal health through cutting-edge molecular and pathogenesis studies of influenza virus and astroviruses. Dr. Schultz-Cherry is a faculty member of the Department of Infectious Diseases at the St. Jude Children’s Research Hospital.